Formosa Laboratories, Inc. (TPE:4746)

Market Cap	6.47B -27.6%
Revenue (ttm)	4.90B +6.7%
Net Income	240.77M -38.7%
EPS	1.99 -38.8%
Shares Out	120.26M
PE Ratio	27.02
Forward PE	n/a
Dividend	3.00 (5.71%)
Ex-Dividend Date	Aug 21, 2025

Volume	687,751
Average Volume	927,256
Open	53.60
Previous Close	52.50
Day's Range	52.80 - 54.20
52-Week Range	49.50 - 76.50
Beta	0.77
RSI	38.71
Earnings Date	Mar 17, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiot...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 280
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4746

Financial Performance

In 2024, Formosa Laboratories's revenue was 4.73 billion, an increase of 8.50% compared to the previous year's 4.36 billion. Earnings were 157.27 million, an increase of 24.58%.